KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY
发明人:
KIM, JAE WHA,OH, SEI RYANG,AHN, KYUNG SEOP,KANG, HO BUM,SHIN, JAE MIN,KO, YOUNG EUN,KIM, MYUNG HWAN,KANG, JONG KOO,SOHN, KI-YOUNG
申请号：
CA2921841
公开号：
CA2921841A1
申请日:
2014.08.18
申请国别(地区):
CA
年份:
2015
代理人:
摘要：
The present invention relates to a composition containing a monoacetyldiglyceride compound as an active ingredient, for inhibiting blood cancer or metastasis, and a use thereof. The monoacetyldiglyceride compound according to the present invention has excellent effects of inhibiting the expression of IL-4 and inhibiting the activity of STAT-6, and thereby is capable of overcoming side effects of currently used blood cancer or metastasis inhibiting agents. Also, the monoacetyldiglyceride compound is a non-toxic compound having superior therapeutic effects and thus can be useful as a composition for preventing, treating, or alleviating blood cancer and metastasis.
